Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
46 participants
INTERVENTIONAL
2010-10-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prgressive Resistance Exercise Training
Progressive Resistance Exercise Training thrice a week for 12 weeks. For first two weeks, 60% of 5 repetition maximum, progressing at 5% of 5 repetition maximum each week reaching upto 110% of 5 Repetition maximum at the end of 12 weeks
Progressive Resistance Exercise Training
Progressive Resistance Exercise Training thrice a week for 12 weeks. For first two weeks, 60% of 5 repetition maximum, progressing at 5% of 5 repetition maximum each week reaching upto 110% of 5 Repetition maximum at the end of 12 weeks
Unstructured Resistance Exercise
Unstructured Resistance Exercise thrice a week for 12 weeks. For 12 weeks, 20% 5 repetition maximum (which will not induce training effect and any physiological responses)and free range of motion exercises with no progression.
Unstructured Nonprogressive resistance exercise
Unstructured Resistance Exercise 30 minutes a day, thrice a week for 12 weeks. For 12 weeks, 20% 5 repetition maximum (which will not induce training effect and any physiological responses)and free range of motion exercises with no progression.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Progressive Resistance Exercise Training
Progressive Resistance Exercise Training thrice a week for 12 weeks. For first two weeks, 60% of 5 repetition maximum, progressing at 5% of 5 repetition maximum each week reaching upto 110% of 5 Repetition maximum at the end of 12 weeks
Unstructured Nonprogressive resistance exercise
Unstructured Resistance Exercise 30 minutes a day, thrice a week for 12 weeks. For 12 weeks, 20% 5 repetition maximum (which will not induce training effect and any physiological responses)and free range of motion exercises with no progression.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be between the ages of 30 - 60 years of age/ both genders.
* Must be able to understand the purpose of exercise testing and resistance training.
Exclusion Criteria
* Those with profound anemia and blood transfusion \< 2 months
* Those underwent renal transplantation \< 6 months.
* Those receiving/ received cytotoxic drugs - amiloride, azathioprine/ aspirin (antiplatelets)\< 2 months
* Those with coagulation disorders or under anticoagulants \< 4 months.
* Those underwent recent cardiac surgeries and with recent unstable cardiac failures
* Those with recent cerebrovascular accidents \< 6 months
* Those have recent urinary tract infections, Renal and bladder carcinomas \< 2 months
* Those with absolute contraindications for resistance exercise training (as per American College of Sports Medicine.
30 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sikkim Manipal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mr. Baskaran Chandrasekaran
Senior Physiotherapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Baskaran Chandrasekaran, MPT
Role: PRINCIPAL_INVESTIGATOR
Lecturer / Consultant cardiopulmonary Physiotherapist
Bidhan C Sharma, MPT
Role: STUDY_CHAIR
Assistant Professor/ Consultant Physiotherapist
Manish Goon, BPT
Role: STUDY_CHAIR
Clinical Physiotherapist
Nikita Joshi, MPT
Role: STUDY_CHAIR
Head of Department/ Associate Professor
Arpan Battacharia, MD
Role: STUDY_CHAIR
Dialysis Unit Incharge
Bidita Kandelwal, MD
Role: STUDY_DIRECTOR
Head of Medicine Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central Referral Hospital, SMIMS
Gangtok, Sikkim, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTRI/2010/091/000014
Identifier Type: -
Identifier Source: org_study_id